ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry Q8N3K9


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name CMYA5_HUMAN
Primary accession number Q8N3K9
Secondary accession numbers A0PJB7 Q05CT4 Q2NKX1 Q2T9G9 Q69YQ8 Q69YQ9 Q6P517 Q6P5U3 Q7Z4I1 Q86T34 Q86T49 Q8N3S4 Q8N3S7 Q8NAG8 Q9UK88
Integrated into Swiss-Prot on April 8, 2008
Sequence was last modified on April 8, 2008 (Sequence version 3)
Annotations were last modified on    September 2, 2008 (Entry version 38)
Name and origin of the protein
Protein name Cardiomyopathy-associated protein 5
Synonyms Myospryn
Dystrobrevin-binding protein 2
SPRY domain-containing protein 2
Tripartite motif-containing protein 76
Genethonin-3
Gene name
Name: CMYA5
Synonyms: C5orf10, DTNBP2, SPRYD2, TRIM76
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature02919; PubMed=15372022 [NCBI, ExPASy, EBI, Israel, Japan]
Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S., Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M., Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
"The DNA sequence and comparative analysis of human chromosome 5.";
Nature 431:268-274(2004).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1682 AND 2600-4069, AND VARIANTS GLY-190; VAL-1295; GLU-3583 AND LEU-4063.
TISSUE=Skeletal muscle;
The German cDNA consortium;
Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-283; 1067-1340; 1604-2691 AND 2754-4069, AND VARIANTS GLY-1920; LEU-2262; GLN-3358; GLU-3583 AND GLN-3927.
TISSUE=Liver, and Skeletal muscle;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1067-1340.
TISSUE=Skeletal muscle;
DOI=10.1038/ng1285; PubMed=14702039 [NCBI, ExPASy, EBI, Israel, Japan]
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [MRNA] OF 1736-2539, INDUCTION, AND TISSUE SPECIFICITY.
DOI=10.1016/S0960-8966(00)00198-X; PubMed=11297942 [NCBI, ExPASy, EBI, Israel, Japan]
Tkatchenko A.V., Pietu G., Cros N., Gannoun-Zaki L., Auffray C., Leger J.J., Dechesne C.A.;
"Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients.";
Neuromuscul. Disord. 11:269-277(2001).
[6]
NUCLEOTIDE SEQUENCE [MRNA] OF 3155-4069, AND VARIANT GLN-3927.
TISSUE=Mammary gland;
Ding P., Han W., Wang L., Wang Y., Qiu X., Xu M., Ma D.;
Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
[7]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-209, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1021/pr070152u; PubMed=17924679 [NCBI, ExPASy, EBI, Israel, Japan]
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
J. Proteome Res. 6:4150-4162(2007).
[8]
INDUCTION.
DOI=10.1074/jbc.M312664200; PubMed=14688250 [NCBI, ExPASy, EBI, Israel, Japan]
Benson M.A., Tinsley C.L., Blake D.J.;
"Myospryn is a novel binding partner for dysbindin in muscle.";
J. Biol. Chem. 279:10450-10458(2004).
[9]
INTERACTION WITH DES.
DOI=10.1074/jbc.M704733200; PubMed=17872945 [NCBI, ExPASy, EBI, Israel, Japan]
Kouloumenta A., Mavroidis M., Capetanaki Y.;
"Proper perinuclear localization of the TRIM-like protein myospryn requires its binding partner desmin.";
J. Biol. Chem. 282:35211-35221(2007).
Comments
  • SUBUNIT: Interacts with ACTN2, DTNBP1/dysbindin and PRKAR2A (By similarity). Interacts with DES.
  • SUBCELLULAR LOCATION: Cytoplasm (By similarity). Cytoplasm, perinuclear region (By similarity). Note=Found predominantly at the periphery of the nucleus but also throughout the cell. Localized at the Z-line costamere connection level of the sarcolemma and in lysosomes (By similarity).
  • TISSUE SPECIFICITY: Expressed in skeletal muscle; at a strong level and in heart.
  • INDUCTION: Down-regulated in muscle cell lines derived from patients with Duchenne muscular dystrophy (DMD).
  • DOMAIN: Amphipathic helix regions act as an anchoring domain for PKA, and appear to be responsible of the interaction between myospryn and PRKAR2A.
  • SIMILARITY: Contains 1 B30.2/SPRY domain.
  • SIMILARITY: Contains 2 fibronectin type-III domains.
  • SEQUENCE CAUTION:
    • Sequence=AAD55265.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence
    • Sequence=AAH20856.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence
    • Sequence=AAH22422.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence
    • Sequence=AAH62664.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence
    • Sequence=AAH63134.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence
    • Sequence=AAI11530.1; Type=Erroneous termination; Positions=3283; Note=Translated as Trp
    • Sequence=CAH10406.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
AC008482; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
AC109488; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
AC008496; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
AL831966; CAD38607.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL831968; CAD38609.2; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL831986; CAD91143.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL832347; CAH10406.1; ALT_SEQ; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL832368; CAD91158.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL832376; CAH10402.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL834252; CAD38928.2; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC020856; AAH20856.1; ALT_SEQ; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC022422; AAH22422.1; ALT_SEQ; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC062664; AAH62664.1; ALT_SEQ; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC063134; AAH63134.1; ALT_SEQ; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC111529; AAI11530.1; ALT_SEQ; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC111530; AAI11531.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AK092699; BAC03950.1; ALT_INIT; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF177292; AAD55265.1; ALT_SEQ; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF533705; AAQ09018.1; ALT_INIT; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
RefSeq NP_705838.3; -.
UniGene Hs.482625
3D structure databases
ModBase Q8N3K9.
Organism-specific databases
HGNC HGNC:14305; CMYA5.
GenAtlas CMYA5.
PharmGKB PA37868; -.
GeneCards Q8N3K9.
Gene expression databases
CleanEx HS_CMYA5; -.
Family and domain databases
InterPro IPR001870; B302.
IPR008957; Fibronectin_typ-III-like_fold.
IPR003961; FN_III.
IPR003877; SPRY_rcpt.
Graphical view of domain structure.
Gene3D G3DSA:2.60.40.30; FN_III-like; 2.
Pfam PF00041; fn3; 2.
PF00622; SPRY; 1.
Pfam graphical view of domain structure.
PRINTS PR01407; BUTYPHLNCDUF.
SMART SM00060; FN3; 2.
SMART graphical view of domain structure.
PROSITE PS50188; B302_SPRY; 1.
PS50853; FN3; 2.
PROSITE graphical view of domain structure (profiles).
BLOCKS Q8N3K9.
Genome annotation databases
Ensembl ENSG00000164309; Homo sapiens. [Contig view]
GeneID 202333; -.
KEGG hsa:202333; -.
Phylogenomic databases
HOVERGEN Q8N3K9; -.
Other
ProtoNet Q8N3K9.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
Coiled coil; Cytoplasm; Phosphoprotein; Polymorphism; Repeat.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
CHAIN   1   4069  4069     Cardiomyopathy-associated protein 5. PRO_0000328722
DOMAIN   3705   3801  97     Fibronectin type-III 1. 
DOMAIN   3802   3894  93     Fibronectin type-III 2. 
DOMAIN   3880   4065  186     B30.2/SPRY. 
REGION   3517   3544  28     Amphipathic helix H1. 
REGION   3545   3672  128     B-box coiled-coil; BBC. 
REGION   3631   3648  18     Amphipathic helix H2. 
REGION   3751   3767  17     Amphipathic helix H3. 
COILED   2964   2988  25     Potential. 
COILED   3544   3653  110     Potential. 
COMPBIAS   20     57  38     Glu-rich. 
COMPBIAS   483    639  157     Glu-rich. 
COMPBIAS   1584   1587  4     Poly-Leu. 
COMPBIAS   1918   1921  4     Poly-Ser. 
MOD_RES   209    209        Phosphotyrosine. 
VARIANT   64     64  1     Y -> C (in dbSNP:rs16877109 [NCBI]). VAR_042471 
VARIANT   175    175  1     Q -> H (in dbSNP:rs6895605 [NCBI]). VAR_042472 
VARIANT   190    190  1     D -> G (in dbSNP:rs10942901 [NCBI]). VAR_042473 
VARIANT   349    349  1     G -> D (in dbSNP:rs1366271 [NCBI]). VAR_042474 
VARIANT   591    591  1     G -> D (in dbSNP:rs16877124 [NCBI]). VAR_042475 
VARIANT   1006   1006  1     V -> A (in dbSNP:rs6893869 [NCBI]). VAR_042476 
VARIANT   1295   1295  1     A -> V (in dbSNP:rs4704585 [NCBI]). VAR_042477 
VARIANT   1309   1309  1     I -> V (in dbSNP:rs16877133 [NCBI]). VAR_042478 
VARIANT   1333   1333  1     A -> V (in dbSNP:rs16877135 [NCBI]). VAR_042479 
VARIANT   1380   1380  1     I -> V (in dbSNP:rs13158477 [NCBI]). VAR_042480 
VARIANT   1567   1567  1     A -> E (in dbSNP:rs1428223 [NCBI]). VAR_042481 
VARIANT   1599   1599  1     S -> A (in dbSNP:rs1428224 [NCBI]). VAR_042482 
VARIANT   1669   1669  1     L -> S (in dbSNP:rs1019762 [NCBI]). VAR_042483 
VARIANT   1713   1713  1     I -> N (in dbSNP:rs16877141 [NCBI]). VAR_042484 
VARIANT   1721   1721  1     I -> V (in dbSNP:rs1428225 [NCBI]). VAR_042485 
VARIANT   1875   1875  1     A -> V (in dbSNP:rs16877147 [NCBI]). VAR_042486 
VARIANT   1917   1917  1     D -> G (in dbSNP:rs16877150 [NCBI]). VAR_042487 
VARIANT   1920   1920  1     S -> G (in dbSNP:rs16877151 [NCBI]). VAR_042488 
VARIANT   2262   2262  1     V -> L (in dbSNP:rs6859595 [NCBI]). VAR_042489 
VARIANT   2383   2383  1     K -> E (in dbSNP:rs7721884 [NCBI]). VAR_042490 
VARIANT   2693   2693  1     T -> I (in dbSNP:rs28362541 [NCBI]). VAR_042491 
VARIANT   2906   2906  1     K -> N (in dbSNP:rs2278239 [NCBI]). VAR_042492 
VARIANT   2935   2935  1     G -> R (in dbSNP:rs2278240 [NCBI]). VAR_042493 
VARIANT   3358   3358  1     H -> Q (in dbSNP:rs3828611 [NCBI]). VAR_042494 
VARIANT   3583   3583  1     K -> E (in dbSNP:rs12514461 [NCBI]). VAR_042495 
VARIANT   3927   3927  1     R -> Q (in dbSNP:rs1129770 [NCBI]). VAR_042496 
VARIANT   4063   4063  1     P -> L (in dbSNP:rs10043986 [NCBI]). VAR_042497 
CONFLICT   79     79        E -> D (in Ref. 2; CAH10406). 
CONFLICT   445    445        A -> V (in Ref. 2; CAH10406). 
CONFLICT   616    616        V -> I (in Ref. 2; CAH10402). 
CONFLICT   654    654        S -> L (in Ref. 2; CAH10406). 
CONFLICT   924    924        N -> D (in Ref. 2; CAH10402). 
CONFLICT   995    995        A -> T (in Ref. 2; CAH10406). 
CONFLICT   1283   1283        S -> P (in Ref. 2; CAH10406). 
CONFLICT   1606   1606        F -> L (in Ref. 2; CAH10406). 
CONFLICT   1681   1681        G -> E (in Ref. 2; CAH10406). 
CONFLICT   1855   1855        S -> G (in Ref. 3; AAH63134). 
CONFLICT   2038   2038        E -> K (in Ref. 3; AAH63134). 
CONFLICT   2148   2148        S -> A (in Ref. 5; AAD55265). 
CONFLICT   2538   2538        G -> D (in Ref. 5; AAD55265). 
CONFLICT   2782   2784        MKE -> TKD (in Ref. 2; CAD38607). 
CONFLICT   2788   2788        S -> P (in Ref. 2; CAD38928). 
CONFLICT   2933   2933        P -> L (in Ref. 2; CAD38607). 
CONFLICT   3073   3113        PQKLNVEEKLSKEVTEETISFPVSSVESALEHEYDL VKLDE -> SFKTIPLPDDSETVACHKTLKSRLEDEKVTPLKENK QKETQ (in Ref. 3; AAH62664). 
CONFLICT   3291   3291        R -> W (in Ref. 2; CAD91143). 
CONFLICT   3321   3321        K -> R (in Ref. 2; CAD91143). 
CONFLICT   3331   3331        V -> A (in Ref. 2; CAD91158). 
CONFLICT   3348   3348        V -> A (in Ref. 2; CAD91158). 
CONFLICT   3361   3361        E -> G (in Ref. 2; CAD91158). 
CONFLICT   3803   3822        APSTPVIRAEDCTVCWNTAT -> GKEMDAKGALEDNAQFFTDS (in Ref. 2; CAD91143). 
CONFLICT   3852   3852        R -> S (in Ref. 2; CAD91158). 
CONFLICT   3880   3880        N -> S (in Ref. 2; CAD91158). 
CONFLICT   3929   3929        T -> A (in Ref. 2; CAD91158). 
CONFLICT   3948   3948        E -> K (in Ref. 2; CAD91158). 
CONFLICT   4050   4050        K -> E (in Ref. 2; CAD38607). 
Sequence information
Length: 4069 AA [This is the length of the unprocessed precursor] Molecular weight: 449211 Da [This is the MW of the unprocessed precursor] CRC64: F5A25F1C53640EB8 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MASRDSNHAG ESFLGSDGDE EATRELETEE ESEGEEDETA AESEEEPDSR LSDQDEEGKI 

        70         80         90        100        110        120 
KQEYIISDPS FSMVTVQRED SGITWETNSS RSSTPWASEE SQTSGVCSRE GSTVNSPPGN 

       130        140        150        160        170        180 
VSFIVDEVKK VRKRTHKSKH GSPSLRRKGN RKRNSFESQD VPTNKKGSPL TSASQVLTTE 

       190        200        210        220        230        240 
KEKSYTGIYD KARKKKTTSN TPPITGAIYK EHKPLVLRPV YIGTVQYKIK MFNSVKEELI 

       250        260        270        280        290        300 
PLQFYGTLPK GYVIKEIHYR KGKDASISLE PDLDNSGSNT VSKTRKLVAQ SIEDKVKEVF 

       310        320        330        340        350        360 
PPWRGALSKG SESLTLMFSH EDQKKIYADS PLNATSALEH TVPSYSSSGR AEQGIQLRHS 

       370        380        390        400        410        420 
QSVPQQPEDE AKPHEVEPPS VTPDTPATMF LRTTKEECEL ASPGTAASEN DSSVSPSFAN 

       430        440        450        460        470        480 
EVKKEDVYSA HHSISLEAAS PGLAASTQDG LDPDQEQPDL TSIERAEPVS AKLTPTHPSV 

       490        500        510        520        530        540 
KGEKEENMLE PSISLSEPLM LEEPEKEEIE TSLPIAITPE PEDSNLVEEE IVELDYPESP 

       550        560        570        580        590        600 
LVSEKPFPPH MSPEVEHKEE ELILPLLAAS SPEHVALSEE EREEIASVST GSAFVSEYSV 

       610        620        630        640        650        660 
PQDLNHELQE QEGEPVPPSN VEAIAEHAVL SEEENEEFEA YSPAAAPTSE SSLSPSTTEK 

       670        680        690        700        710        720 
TSENQSPLFS TVTPEYMVLS GDEASESGCY TPDSTSASEY SVPSLATKES LKKTIDRKSP 

       730        740        750        760        770        780 
LILKGVSEYM IPSEEKEDTG SFTPAVAPAS EPSLSPSTTE KTSECQSPLP STATSEHVVP 

       790        800        810        820        830        840 
SEGEDLGSER FTPDSKLISK YAAPLNATQE SQKKIINEAS QFKPKGISEH TVLSVDGKEV 

       850        860        870        880        890        900 
IGPSSPDLVV ASEHSFPPHT TEMTSECQAP PLSATPSEYV VLSDEEAVEL ERYTPSSTSA 

       910        920        930        940        950        960 
SEFSVPPYAT PEAQEEEIVH RSLNLKGASS PMNLSEEDQE DIGPFSPDSA FVSEFSFPPY 

       970        980        990       1000       1010       1020 
ATQEAEKREF ECDSPICLTS PSEHTILSDE DTEEAELFSP DSASQVSIPP FRISETEKNE 

      1030       1040       1050       1060       1070       1080 
LEPDSLLTAV SASGYSCFSE ADEEDIGSTA ATPVSEQFSS SQKQKAETFP LMSPLEDLSL 

      1090       1100       1110       1120       1130       1140 
PPSTDKSEKA EIKPEIPTTS TSVSEYLILA QKQKTQAYLE PESEDLIPSH LTSEVEKGER 

      1150       1160       1170       1180       1190       1200 
EASSSVAAIP AALPAQSSIV KEETKPASPH SVLPDSVPAI KKEQEPTAAL TLKAADEQMA 

      1210       1220       1230       1240       1250       1260 
LSKVRKEEIV PDSQEATAHV SQDQKMEPQP PNVPESEMKY SVLPDMVDEP KKGVKPKLVL 

      1270       1280       1290       1300       1310       1320 
NVTSELEQRK LSKNEPEVIK PYSPLKETSL SGPEALSAVK MEMKHDSKIT TTPIVLHSAS 

      1330       1340       1350       1360       1370       1380 
SGVEKQVEHG PPALAFSALS EEIKKEIEPS SSTTTASVTK LDSNLTRAVK EEIPTDSSLI 

      1390       1400       1410       1420       1430       1440 
TPVDRPVLTK VGKGELGSGL PPLVTSADEH SVLAEEDKVA IKGASPIETS SKHLAWSEAE 

      1450       1460       1470       1480       1490       1500 
KEIKFDSLPS VSSIAEHSVL SEVEAKEVKA GLPVIKTSSS QHSDKSEEAR VEDKQDLLFS 

      1510       1520       1530       1540       1550       1560 
TVCDSERLVS SQKKSLMSTS EVLEPEHELP LSLWGEIKKK ETELPSSQNV SPASKHIIPK 

      1570       1580       1590       1600       1610       1620 
GKDEETASSS PELENLASGL APTLLLLSDD KNKPAVEVSS TAQGDFPSEK QDVALAELSL 

      1630       1640       1650       1660       1670       1680 
EPEKKDKPHQ PLELPNAGSE FSSDLGRQSG SIGTKQAKSP ITETEDSVLE KGPAELRSRE 

      1690       1700       1710       1720       1